Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at StockNews.com
Analysts at StockNews.com assumed coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Get Free Report) in a research report issued on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their price objective on Minerva Neurosciences from $11.00 to $7.00 and set a “neutral” rating on the stock […]
More Stories
Amplify Cybersecurity ETF (NYSEARCA:HACK) Sets New 52-Week High – Still a Buy?
Amplify Cybersecurity ETF (NYSEARCA:HACK – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday ....
Vulcan Forged PYR Price Up 0% Over Last Week (PYR)
Vulcan Forged PYR (PYR) traded 0.9% higher against the dollar during the 24 hour period ending at 7:00 AM Eastern...
Truist Financial Reaffirms “Buy” Rating for Microsoft (NASDAQ:MSFT)
Truist Financial restated their buy rating on shares of Microsoft (NASDAQ:MSFT – Free Report) in a research note released on...
KeyCorp Trims Micron Technology (NASDAQ:MU) Target Price to $135.00
Micron Technology (NASDAQ:MU – Free Report) had its target price trimmed by KeyCorp from $145.00 to $135.00 in a research...
Valero Energy (NYSE:VLO) Rating Increased to Overweight at Wells Fargo & Company
Valero Energy (NYSE:VLO – Get Free Report) was upgraded by equities researchers at Wells Fargo & Company from an “equal...
Etsy’s (ETSY) “Neutral” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reiterated their neutral rating on shares of Etsy (NASDAQ:ETSY – Free Report) in a research report released on...